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Abstract
The ultimate stage of the transmission of Dengue Virus (DENV) to man is strongly dependent on crosstalk between the virus
and the immune system of its vector Aedes aegypti (Ae. aegypti). Infection of the mosquito’s salivary glands by DENV is the
final step prior to viral transmission. Therefore, in the present study, we have determined the modulatory effects of DENV
infection on the immune response in this organ by carrying out a functional genomic analysis of uninfected salivary glands
and salivary glands of female Ae. aegypti mosquitoes infected with DENV. We have shown that DENV infection of salivary
glands strongly up-regulates the expression of genes that encode proteins involved in the vector’s innate immune
response, including the immune deficiency (IMD) and Toll signalling pathways, and that it induces the expression of the
gene encoding a putative anti-bacterial, cecropin-like, peptide (AAEL000598). Both the chemically synthesized non-cleaved,
signal peptide-containing gene product of AAEL000598, and the cleaved, mature form, were found to exert, in addition to
antibacterial activity, anti-DENV and anti-Chikungunya viral activity. However, in contrast to the mature form, the immature
cecropin peptide was far more effective against Chikungunya virus (CHIKV) and, furthermore, had strong anti-parasite
activity as shown by its ability to kill Leishmania spp. Results from circular dichroism analysis showed that the immature
form more readily adopts a helical conformation which would help it to cause membrane permeabilization, thus permitting
its transfer across hydrophobic cell surfaces, which may explain the difference in the anti-pathogenic activity between the
two forms. The present study underscores not only the importance of DENV-induced cecropin in the innate immune
response of Ae. aegypti, but also emphasizes the broad-spectrum anti-pathogenic activity of the immature, signal peptide-
containing form of this peptide.
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Introduction
The recent emergence of dengue constitutes a serious health
threat and today, the disease is considered one of the most serious
arthropod-borne human viral diseases in terms of both morbidity
and mortality [1], with approximately 50–100 million new
infections per annum, including 200,000–500,000 cases of
potentially life-threatening dengue hemorrhagic fever or dengue
shock syndrome [2,3] which is the leading cause of infant mortality
in several Asian countries. The National Institute of Allergy and
Infectious Diseases has classified DENV as a category A biothreat
pathogen. There is currently no licensed vaccine or drug treatment
against this pathogen and, at present, the only method of
preventing transmission is by controlling its vector, the Ae. aegypti
and Aedes albopictus (Ae. albopictus) mosquitoes. Dengue viruses
circulate in nature as four distinct serological types (DENV-1 to -4)
which are ingested by the vector when it feeds on an infected host.
The virus then crosses the gut epithelium into the hemolymph to
reach the salivary glands via various routes. Once in the insect’s
saliva, it is inoculated into a vertebrate host to recommence its
replicative cycle [4].
An important consequence of this transmission process is the
interference of DENV with both the invertebrate and human
immune systems. While infection of vertebrates causes severe disease,
thepresence ofDENV inmosquitoes isnon-pathogenicand results in
life-long, persistent infection. This difference may reflect the capacity
of insects to mount a highly effective innate immune response of both
cellular and humoral nature to control invading microbes [5,6].
PLoS Pathogens | www.plospathogens.org 1 January 2011 | Volume 7 | Issue 1 | e1001252The immune pathways and effectors activated in response to
pathogens in Ae. aegypti still remain elusive. However, recent studies
have shown that oral infection with DENV elicits dsRNA and
production of DENV-specific siRNAs in the midgut [7],
supporting a major role for the RNAi pathway in the control of
DENV replication in Ae. aegypti. In addition, the Toll and the Janus
kinase/signal transduction and activators of transcription (JAK-
STAT) pathways have also been reported to play an important
role in controlling DENV replication in the midgut [8,9]. Finally,
the recent sequencing and annotation of the Ae. aegypti genome is of
importance to identify new effectors in the immune system of this
vector [10].
However, although the salivary gland of Ae. aegypti is the final
organ required to be infected prior to the transmission of DENV
to humans, the complex relationship between this organ and the
virus remains unknown. Antimicrobial peptides (AMP), lysozyme,
and pathogen pattern recognition receptors are commonly found
in the salivary gland of many hematophagous arthropods, pointing
to the importance of this organ in the vector’s immune defense
mechanism [11,12]. For example, a recently discovered tick
protective antigen, subolesin, reportedly is active against patho-
gens in the salivary gland via NF-kB-dependent and independent
signal transduction pathways that regulate innate immune
responses [13]. Moreover, several defense response genes have
been found in the salivary gland EST clusters of biting midge
Culicoides sonorensi [14]. It is of note that a comparative
transcriptome analysis of plasmodium-infected Anopheles gambiae
salivary glands also revealed the induction of several innate
immune response genes, encoding proteins such as prophenolox-
idases and AMP [15].
In order to decipher the complex relationship between DENV
and the innate immune system of Ae. aegypti, we have investigated
whether the expression of some acute-phase proteins is modulated
in salivary glands following infection of the vector by DENV. To
this aim, using the Digital Gene Expression (DGE) analysis
combined with a deep sequencing approach, we have carried out a
comparative genomic analysis of uninfected salivary glands and
salivary glands of female Ae. aegypti mosquitoes infected with
DENV (referred to in the present study as uninfected and DENV-
infected salivary glands). Among the up-regulated genes, we have
identified a putative antibacterial peptide, belonging to the
cecropin family, indicating that the IMD pathway is involved in
the mosquito’s defense against DENV in salivary glands. We
further demonstrate that the immature, signal peptide-containing
form of this peptide displays wide anti-infectious properties and is




Venous blood from anonymous healthy human volunteers was
obtained from the blood bank (Etablissement Franc ¸ais du Sang) in
accordance with its guidelines, published in the French Journal
Officiel, with informed written consent from each volunteer. The
study was conducted according to the guidelines of the
Institutional Review Board of the Institut de Recherche pour le
De ´veloppement and was approved by the Institutional Review
Board of the Institut de Recherche pour le De ´veloppement.
Cells and viruses
Ae. albopictus C6/36 cells, used for the propagation of the four
dengue serotypes DENV-1 (Hawaii strain [16]), DENV-2 (16681
strain [16]), DENV-3 (H87 strain [16]) and DENV-4 (814669
strain [17]) were grown in M199 medium (Invitrogen, France),
supplemented with 10% fetal calf serum (FCS, Lonza, Switzer-
land) at 28uC. All DENV serotypes were passed three times in C6/
36 cells. HEK-293T (Human Embryonic Kidney 293) and LLC-
MK2 (Monkey kidney epithelial) cells were grown in DMEM,
10% FCS, at 37uC.
Mosquito infection and sample preparation
The Ae. aegypti mosquito strain used in our study was a Liverpool
strain originating from West Africa which has been maintained at
the Liverpool School of Tropical Medicine since 1936 [18].
Mosquitoes were reared and maintained at 26uC60.5uC with 75–
80% relative humidity and a 12:12 h (light:dark) photoperiod.
Infectious blood meals were offered 3 days post-emergence to
adult, female, Ae. aegypti mosquitoes using a silicone membrane
feeder system [19]. Human blood was combined (1:1) with the
culture supernatant of C6/36 cells infected with DENV-2 16681
to provide a titrated blood meal of 5.10
6 plaque forming units
(PFU)/ml. For the control group of mosquitoes, human blood was
mixed in the same proportion with culture supernatant of
uninfected C6/36 cells. Mosquitoes that failed to feed were
discarded. At different time-points after the blood meal, salivary
glands were carefully dissected in Phosphate Buffered Saline (PBS)
and washed 3 times with PBS to prevent contamination with the
fat body [11]. Each pair of salivary gland was frozen separately at
280uCi n2 0mL acid guanidium thiocyanate-phenol-chloroform
solution (RNable Eurobio, France). Before use of salivary glands
for further experiments, the RNA of carcasses corresponding to
the group of mosquitoes fed with infectious blood meal was
extracted individually and tested for the presence of DENV by
semi-quantitative PCR. Glands of mosquitoes containing DENV
were then pooled (40 pairs of salivary for each time point) and
lysed with 500 mL of RNable. RNA was precipitated following the
addition of isopropanol, collected by centrifugation at 120006g for
15 minutes and washed once with 75% ethanol. After a brief air-
drying, the pellet was dissolved in RNase/DNase free water.
Author Summary
Dengue viruses (DENV) are generally maintained in a cycle
which requires horizontal transmission via their arthropod
vector, Ae. aegypti, to the vertebrate host. One important
consequence of this process is the interference of the virus
with the immune systems of both the mosquito and its
host. While infection of humans causes disease, the
presence of DENV in mosquitoes gives rise to life-long
and persistent infection with active viral replication in the
salivary glands. In the present study, we have evaluated
the mosquito’s immune response following DENV infec-
tion by analyzing the gene expression profile of infected
and uninfected salivary glands. The results show that DENV
infection activates signaling pathways and induces the
expression of gene products that are involved in the
innate immune response to DENV infection, and in
particular a putative antibacterial cecropin-like peptide.
The immature and mature forms of this peptide were
found to be active against a variety of pathogens including
DENV and Chikungunya viruses, as well as the Leishmania
parasite. This study is the first to establish a comparative
analysis of uninfected salivary glands and salivary glands of
female Ae. aegypti mosquitoes infected with DENV. We
demonstrate that certain DENV-induced peptides possess
broad-spectrum anti-pathogenic activity and may have
therapeutic potential in the treatment of human infectious
disease.
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RT-PCR was carried out on 2 mg of salivary gland RNA using
the QIAGEN OneStep RT-PCR kit and 15 pmol of specific
primers: DF: 59 TCA-ATA-TGC-TGA-AAC-GCG-CGA-GAA-
GAA-ACC-G39; DR: TTG-CAC-CAA-CAG-TCA-ATG-TCT-
TCA-GGT-TC39. The PCR steps were: 50uC for 30 min, 95uC
for 15 min, 39 cycles (94uC for 1 min, 55uC for 30 sec, 72uC for
1 min), 72uC for 10 min. The quality of the total RNA was
checked by capillary electrophoresis analysis using an Agilent
BioAnalyser 2100 (Agilent, Palo Alto, CA, USA) and quantities
were measured using a NanoDrop ND-1000 spectrophotometer
(Thermo Scientific, Les Ulis, France).
Sequence tag preparation
Sequence tags were prepared with the Illumina Digital Gene
Expression Tag Profiling Kit following the manufacturer’s
protocol (version 2.1B). One microgram of total RNA was
incubated with oligo-dT beads to capture the polyadenlyated
RNA fraction. First- and second-strand cDNA synthesis were
performed while the RNA was bound to the beads. Still on the
beads, samples were digested with NlaIII to retain a cDNA
fragment from the most 39 CATG to the poly (A)-tail.
Subsequently, the GEX adapter 1 was ligated to the free 59 end
of the RNA, and the sample was digested with MmeI which cuts
17 bp downstream of the CATG site. At this point, the fragments
detach from the beads. After dephosphorylation and phenol
extraction, the GEX adapter 2 was ligated to the 39 end of the tag.
To enrich for the desired fragments, 15 cycles of PCR
amplification with the Phusion polymerase (Finnzymes Espoo,
Finland) were performed with primers complementary to the
adapter sequences. The resulting 85 bp fragments were purified by
excision from a 6% polyacrylamide TBE gel. The DNA was eluted
with 16 NEBuffer 2 by gentle rotation for 2 h at room
temperature. Gel debris was removed using a Spin-X Cellulose
Acetate Filter (2 ml, 0.45 mm) and the DNA was precipitated by
adding 10 ml of 3 M sodium acetate (pH 5.2) and 325 mlo f
ethanol (220uC), followed by centrifugation at 14,000 rpm for
20 min. After washing of the pellet with 70% ethanol, the DNA
was resuspended in 10 ml of 10 mM Tris–HCl, pH 8.5 and
quantified using a Nanodrop 1000 spectrophotometer.
Sequencing
Cluster generation was performed after applying 4 pM of each
sample to individual lanes of an Illumina 1G flowcell. After
hybridization of the sequencing primer to the single-stranded
products, 18 cycles of base incorporation were carried out on the
1G analyzer according to the manufacturer’s instructions. Image
analysis and base calling were performed using the Illumina
Pipeline and sequence tags were obtained after purity filtering.
This was followed by sorting and counting of the unique tags.
DGE libraries were registered in Gene Expression Omnibus
(GEO, NCBI) under account number GSM537747 for uninfected
salivary glands and GSM537746 for DENV-infected salivary
glands.
DGE tag annotation and comparison of expression data
Generation of expression matrices, data annotation, filtering
and processing were performed using BIOTAG software (Skuld-
Tech, France) [20]. First, flat files were downloaded from the
GenBank (UniGene Build #12) and Ensembl (AaegL1, Jun 2009)
databases. A table was constructed by extracting virtual tags from
the representative sequences associated with each UniGene and
Ensembl cluster file. Then BIOTAG functions were used for tag-
to-gene assignment and subsequent data management. A query
using tag sequence as the primary key allowed us to match
experimentally obtained DGE sequences and virtual sequences
with pre-selected annotations. Results are displayed in a table that
provides the sequence of each DGE tag, its number of occurrences
with the matching cluster number, its location in the sequence and
other data extracted from the source file, including GenBank/
Ensembl accession numbers.
The statistical value of DGE data comparisons, as a function of
tag counts, was calculated by assuming that each tag has an equal
chance of being detected. For several highly expressed transcripts,
we checked that tag frequencies in successive sequence batches
were distributed in agreement with a binomial law [20]. Selected
genes were chosen based on a comparison between the two
libraries, combined with the significance threshold of the observed
variations (p-value,0.01).
DENV-2 quantitative real-time PCR
Total RNA was extracted from salivary glands using RNable
(Eurobio, France) following the manufacturer’s protocol. The RNA
was resuspended in 30 mL of RNAse-free distilled water and stored
at 280uC. Subsequently, 0.6 mg of each RNA was reverse-
transcribed using the SuperSript VILO cDNA Synthesis Kit
(Invitrogen, Cergy Pontoise, France) following the manufacturer’s
instructions. TaqMan universal PCR master mix (Applied Biosys-
tems, Courtaboeuf, France) was used in all qPCR procedures. Each
reaction of 50 ml contained 300 nM of forward primer Denv_F
59AGGACYAGAGGTTAGAGGAGA39), 300 nM of reverse pri-
mer (Denv_R 59CGYTCTGTGCCTGGAWTGAT39), 150 nM
of specific probe (Denv_P 6FAM_59ACAGCATATTGACG-
CTGGGARAGACC39_TAMRA) and 16 TaqMan universal
PCR master mix. Primers and probe sequences targeted all dengue
serotypes [21]. Amplification in an Applied Biosystem 7300 real-
time PCR system involved activation at 95uC for 10min followed by
40 amplification cycles of 95uC for 15 sec, 60uC for 15 sec and
72uC for 30 sec. Real-time data were analyzed using SDS software
from Applied Biosystems. Viral RNA was quantified by comparing
the sample’s threshold cycle (Ct) values with a the Dengue virus
RNA standard curve which was obtained as follows: firstly, total
viral RNA from the cell culture was purified using QIAamp Viral
RNA kit (Qiagen, Courtaboeuf, France) following the manufactur-
er’s protocol. Then, standard RT-PCR was carried out by using a
primer containing the T7 promoter sequence (T7_Denv_F
59TAATACGACTCACTATAGGAGGACYAGAGGTTAGAG-
GAGA39, Denv_R 59CGYTCTGTGCCTGGAWTGAT39). The
PCR product, containing the T7 promoter sequence was used to
generate Dengue RNA fragments by in vitro transcription using the
MAXIscript kit (Ambion, Austin Texas, USA). Then, RNA was
purified by precipitation in sodium acetate and absolute ethanol.
The amount of RNA generated was determined by spectropho-






RNA standards containing 10
10 to 10
2 RNA copies were used to
construct a standard curve.
DENV immunolabeling
At various days following infection of female Ae. aegypti
mosquitoes, DENV-infected and uninfected salivary glands were
dissected in PBS and fixed in 100% acetone at 220uC for 1h. The
Dengue Virus-Induced Broad-Spectrum AMP
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X-100 to prevent non-specific staining and incubated overnight
with the monoclonal 3H5 antibody which is directed against the
DENV-2 envelope protein. Cells were washed with PBS and
incubated overnight with phalloidin-Tetramethyl Rhodamine Iso-
Thiocyanate (TRITC) at 4uC. Hoechst dye was used to stain the
nucleus and preparations were examined with a confocal
microscope Zeiss 5 Live Duo, as previously described [22].
AAEL 000598 immunohistochemistry
5 days after the infection of female Ae. aegypti mosquitoes,
DENV-infected and uninfected salivary glands and fat body were
dissected in PBS and fixed with 4% paraformaldehyd at 220uC
for 1h. The tissue was incubated for 30 min in 10% goat serum
0.3% Triton X-100 to prevent non-specific staining and incubated
overnight with the AAEL000598-specific polyclonal antibody.
Cells were washed with PBS and incubated overnight with
Hoechst dye at 4uC to stain the nucleus. Preparations were
examined as described above.
Real-time PCR analysis of AAEL000598
cDNA was synthesized using 700ng salivary gland RNA (ten
pooled salivary glands for each time point) or carcass and the
MMLV reverse transcription Kit, following the manufacturer’s
protocol (Invitrogen, France). PCR reactions were run following
the Roche Light Cycler LC480 protocol. PCR was performed
using 1 ml of first cDNA, 3.33 mM of each primer and 2.5 mlo f
SYBR Green (Roche, France) in a 4 ml reaction volume. The
cycling conditions were 40 cycles of 95uC for 10s, 57uC for 20s,
and 72uC for 25s. RNA was quantified by calculating 2
2DDCT.
Normalization was performed using a set of two internal control
genes, the 40S ribosomal protein S17 and the ribosomal protein
L28. The following specific primers were used: AAEL000598:
forward 59-GCTGTTCGCAATTGTGCTGTT-39, reverse 59-
CAATTTCTTTCCCAGCTTCTTCA-39; 40S ribosomal pro-
tein S17: forward 59-CGCTGGTTTCGTGACACATC-39, re-
verse 59-TCTCTGCGCTCACGTTCCT-39 and ribosomal pro-
tein L28: forward 59-CCACGGTTAAGGTTACGCTGAA-39,
reverse 59-CGACGGTAACGGTTCTTGTTG-39.
SELDI-TOF-MS
Surface-enhanced laser desorption ionisation time of flight mass
spectrophotometry (SELDI-TOF-MS) Protein-Chip arrays
(Biorad, France) were used as previously described [23]. Briefly,
salivary gland extracts (from 4 groups of infected and uninfected
mosquitoes) were diluted in a binding buffer (100 mM ammonium
acetate, pH 4) and applied to the cation exchanger (CM10) chip.
After 24h incubation at 4uC, unbound proteins were removed by
three successive 5-minute washes with a buffer containing
100 mM ammonium acetate, Triton X-100 and 5 mM Hepes
(pH 7). Chip-captured proteins were air-dried and covered with a
matrix (3,5-dimethoxy-4-hydroxycinnapynic acid (SPA) in 99.9%
acetonitrile and 0.1% trifluoroacetic acid), used to absorb laser
energy. The ionized and desorbed proteins were detected and
their molecular masses displayed on the proteogram. Peaks were
determined using SELDI-TOF-MS analysis with Protein-Chip
Biology System 3.5 software.
Depletion of the 3.8 kDa MW protein from infected
salivary glands
Depletion of the 3.8 kDa MW peptide from infected salivary
glands was achieved by adding magnetic Bio-Adembeads coupled
with protein G (Ademtech, France), pre-incubated for 2 h at 4uC
with an anti-GK pAb After overnight incubation at 4uC followed
by magnetic bead removal, the supernatant was analyzed by
SELDI-TOF-MS.
The GK-specific polyclonal antibody was raised in rabbits
following the immunization with the GK peptide and purified
from immune serum by a GK-Sepharose affinity chromatography.
This antibody binds to both uncleaved and cleaved AMP (data not
shown).
Peptide synthesis
Ae. aegypti peptides were chemically synthesized by Proteogenix
(France) and checked by mass spectrometry (purity over 95%).
The sequences of GK and MK peptide are: GK: GGLK-
KLGKKLEGAGKRVFKASEKALPVVVGIKAIGK; MK: MN-
MNFTKLFAIVLLAA LVLLGQTEAGGLKKLGKKLEGAG-
KRVFKASEKALPVVVGIKAIGK. The Ae. aegypti peptide (MT
peptide) that has an irrelevant sequence, but a MW (6624.73 g/
mol) similar to that of the MK peptide has been used as negative
control. The sequence of the MT (AAEL000160) peptide is:
MTLERIQETPALKGAPLSPLLRSLSGTLCMISQQRSVSHR-
T SKYSSNRHRKLQPFRET. In addition, a peptide (SC) of
identical amino acid composition as the GK peptide, but with a
scrambled sequence, has been used in the antibacterial assay. The
sequence of the SC peptide is: VAKGLIKGVKAKGEL-
PAKGVFKGLKESIGKRAVLKG.
Antibacterial assays
Escherichia coli bacteria were cultured in LB medium with or
without peptide. After overnight incubation at 37uC, bacterial
growth was estimated by measuring the change in OD600nm on a
microplate spectrophotometer. The synthetic peptides’ minimum
inhibitory concentrations (MICs) of each of the synthetic peptides
were expressed as the lowest concentration of the peptide that
completely inhibited bacterial growth.
Effect of peptides on DENV infection
The effect of peptides on viral production was assessed in
permissive Ae. albopictus C6/36 cells infected with Dengue virus
serotype 1–4 at a multiplicity of infection (MOI) of 1. Briefly, cells
were exposed to DENV for 1 h at 4uC. Unbound virus was
removed by washing cells 3 times with cold medium. Cells were
then incubated for 24 h with different concentrations of GK or
MK peptides (5 mg/ml and 10 mg/ml). The MT peptide at 10 mg/
ml was used as a control in this experiment. Level of infection was
determined by quantification of viral RNA by real-time PCR as
described above.
Measurement of viral titer by plaque assays
The consequence of peptide treatment on productive infection
of mosquito cells was assayed as follows. Supernatants from
DENV-infected C6/36 cells maintained in the presence of 10 mg/
ml of peptides (GK, MK and MT) were collected at 24 h post
infection (hpi). The production of viral particles in supernatants
was determined by plaque titration assay on adherent permissive
LLC-MK2 cells, which are permissive to all DENV serotypes.
Briefly, LLC-MK2 cells were seeded in 6-well plates for 24 h at
37uC. After cell propagation, growth medium was removed and
serial dilutions of Viral supernatants in DMEM 10% FCS were
added to the cells. The inoculated cells were further incubated for
1 h at 37uC. Fresh 26 nutrient medium (Earle’s balance salts
supplemented with 0.07% (w/v) yeast extract, 0.33% (w/v)
lactalbumin hydrolysate, 4% FBS, 7.5% NaHCO3, 2% essential
amino acid) containing 1.5% agarose (Seakem) was added into
Dengue Virus-Induced Broad-Spectrum AMP
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and plaques were visualized 5 to 7 days later, after addition of a
second overlay of the above agarose solution supplemented with
neutral red (0.1 mg/ml). The virus titre is expressed as Plaque
Forming Unit (PFU) per millilitre.
Effect of peptides on Chikungunya virus infection
Permissive HEK-293T cells were incubated with CHIKV
(Strain 147-2-GFP) at a MOI of 1 and increasing concentrations
of GK, MK or MT peptides. After 2 h at 37uC, viral input was
removed and replaced by fresh medium supplemented or not with
the peptides. After an additional 48 h in culture, the percentage of
infected cells was directly related to the number of GFP-labelled
cells counted by flow cytometry. A minimum of 10,000 cells were
analyzed for each data point.
Cytotoxicity assays
Cell viability was determined using a 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT)-based assay (Sigma,
France) [24]. Cells were set up and incubated with peptides under
conditions that were identical to those used for antiviral assays.
The cellular viability was determined measuring the absorbance
values at 570 nm that were plotted against peptide concentrations
to determine the IC50 values.
Leishmanicidal activity
Leishmania infantum (strain MHOM/MA/67/ITMAP-263) and
Leishmania braziliensis (strain MHOM/BR/75M2904) promasti-
gotes expressing the luciferase gene were used to test the anti-
leishmanial activities of the AMP as previously described [25,26].
Briefly, 10
5 promastigotes were inoculated into aliquots of 100 ml
of medium in 96 well plates. After 4 h, the GK, MK or MT
peptides were added and the plate was incubated for another 72 h
before luciferase activity was assayed. Results are expressed as the
relative light units (RLU) index (=[RLU in treated wells/RLU in
untreated wells]6100), whereas 100% represents parasite growth
in the absence of peptides.
Circular Dichroism (CD)
CD was performed to determine the peptides’ secondary
structures. CD spectra of peptide solutions in PBS or in different
concentrations of trifluoroethanol (10%, 20% and 40%) were
obtained using a Chirascan Circular Dichroism Spectrometer
(Applied Photophysics, United Kingdom) at 20uC, with a water-
jacketed quartz cell of 1 mm path length. Wavelengths from 188
to 260 nm were measured with a step resolution of 0.5 nm and a
bandwidth of 5 nm. CD spectra were generated from an average
of 2 scans of each sample. Secondary structures were determined
using Chirascan software. The mean residue ellipticity [h] (in
degrees.cm
2.dmol
21) was calculated using [h]=[h]obs(MRW/
10.l.c), where[h]obs is the ellipticity measured in millidegrees,
MRW is the peptide’s mean residue MW, c is the concentration of
sample in mg mL
21, and l is the optical path length in cm. Spectra
were plotted as molar ellipticity [h] versus wavelength.
Accession numbers
The Ensembl or Entrez gene ID for the genes and proteins cited
in the text is: AAEL000598 (putative antibacterial peptide,
cecropin); AAEL000160 (hypothetical protein); AAEL014640
(peptidoglycan recognition protein-lc isoform); AAEL007064
(gram-negative bacteria binding protein); AAEL007619 (Toll);
AAEL007768 (MYD88); AAEL003849 (hypothetical protein,
defensin); AAEL003857 (hypothetical protein, defensin);
AAEL009670 (lysozyme P); AAEL015639 (transferrin); 5565542
(diptericin).
Results
High-throughput deep sequencing of the Ae. aegypti
salivary gland transcriptome response to DENV infection
Salivary glands from Ae. aegypti females were collected at various
time points following oral infection with DENV-2, and the kinetics
of infection, as detected by the presence of viral transcripts, were
monitored by real-time PCR. Viral transcripts could already be
detected in the salivary glands 24 h after infection, albeit at very
low levels (1.5 log10 RNA copies per pair of salivary glands). The
expression of DENV transcripts increased over time until 14 days
after infection (Figure 1). Because of the likelihood that salivary
gland genes targeted by DENV are modulated with differential
kinetics, we compared the transcriptomes of DENV-infected and
uninfected salivary glands at a series of time points between 1 and
14 days after the blood meal, with the aim to follow the changes in
the overall gene expression profile throughout DENV infection.
From this comprehensive analysis of gene expression profiles,
more than 11 million DGE tags were sequenced. Among them,
39,912 unique tags with an occurrence of over 10 were detected.
Thirty nine percent of these matched annotated genes in the
GenBank and Ensembl databases (Supporting Information, Table
S1). Based on criteria of probability (p,0.01) and the strength of
induction (.2-fold), 1,111 transcripts were selected the expression
of which was up-regulated in uninfected salivary glands, and 649
that were up-regulated in DENV-infected salivary glands (Sup-
porting Information, Table S1).
Salivary glands from DENV-infected mosquitoes
overexpress a 3.8 kDa peptide
Among the most strongly up-regulated genes in DENV-infected
Ae. Aegypti salivary glands, we identified a gene belonging to the
cecropin family (AAEL000598) (Table 1), a family of small cationic
antimicrobial peptide that are induced in insects in response to
hypodermic injury or bacterial infection [5]. Real-time quantita-
tive PCR analysis was carried out to confirm the result obtained by
DGE analysis and to investigate the chronology of the expression
Figure 1. Follow-up of DENV-2 replication in the salivary
glands from Ae. aegypti. At different time points after an infectious
blood meal, propagation of DENV to salivary glands was investigated by
real-time RT-PCR amplification of viral RNA in 80 pooled salivary glands
for each time point post infection. Data are representative of three
independent experiments (error bars represent standard error of the
mean).
doi:10.1371/journal.ppat.1001252.g001
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compared with the expression profile observed in uninfected
samples, a mRNA peak expression was detected 5 days post
infection (dpi) in infected salivary glands (Figure 2A). Salivary
glands were harvested from infected and uninfected mosquitoes at
different time points to corroborate the over-expression of the
AAEL000598 AMP, using the SELDI-TOF-MS technique.
Results from this analysis revealed the presence of a peptide with
a MW of 3.68 kDa that was more highly expressed in infected
than in uninfected organs at 5, 9 and 14 dpi (Figure 2B).
Incubation of 10 pooled salivary glands, collected at 5 dpi, with
a polyclonal antibody raised against a synthetic peptide derived
from the AEEL000598 sequence, immobilized onto protein G
beads, followed by depletion of the Ab-peptide complex, resulted
in the complete removal of the 3.68 kDa peak from the mass
spectrometry peptide profile. This result confirms that the
identified AMP in DENV-infected salivary glands corresponds to
the cecropin AAEL000598 gene product (Figure 2B). Expression
of AAEL000598 in salivary glands at 5 dpi was confirmed using
immunofluorescence analysis (Supporting Information, Figure S1).
In contrast, the peptide was not detected in the fat body at the
same time point following DENV infection. Then we investigated
whether the expression profile for AAEL000598 matched the
kinetics of virus replication. Salivary glands isolated from
mosquitoes at different time points post infection were prepared
for confocal microscopy and labelled with a mouse monoclonal
antibody specific for the DENV-2 envelope. Interestingly, the viral
envelope protein was detected starting at 5 dpi (Figure 3). Our
results suggest that the immune response against DENV in the
salivary gland is activated early through intracellular signalling
pathways that induce expression of this AMP.
Antibacterial activities of the AMP
In order to corroborate the supposed antibacterial activity of the
identified AMP, its immature, signal sequence-containing, form
(called MK) and its mature form (called GK) (Supporting
Information, Figure S2) were chemically synthesized and their
potency was evaluated in antibacterial tests. Both peptides were
tested on the Gram-negative strain E. coli (Figure 4). Both the GK
and the MK peptides killed E. coli in a dose-dependent manner
with minimum inhibitory concentrations of 0.625 mM (GK) and
5 mM (MK), (Figure 4), respectively, which is consistent with a
previous report showing that cecropins preferentially target gram-
negative bacteria [27]. The Ae. aegypti MT peptide (AAEL000160)
which has been reported in the Ensembl data base as a
hypothetical protein with a MW similar that of MK peptide,
used as a negative control in these experiments had no effect on
bacterial growth. Similar results were also obtained with a peptide
of identical amino acid composition to the GK peptide but with a
scrambled sequence (Figure 4).
Antiviral properties of the putative antimicrobial peptide
Next, antiviral activity of GK and MK peptides against DENV
replication was tested in permissive C6/36 cells infected with each
of the four DENV serotypes and treated with various concentra-
tions of the GK, MK or with the MT control peptide. Twenty-four
h post-infection, quantitative real-time PCR was performed to
measure viral RNA accumulation in C6/36 cells (Figure 5). The
results show that intracellular viral RNA levels in DENV-infected
C6/36 cells incubated in the presence of GK or MK peptides were
reduced, in a dose dependent manner, when compared with levels
detected from control cells infected with DENV and maintained in
the presence of medium alone or cultured with the MT peptide.
Under these experimental conditions, the MK peptide was
approximately 10-fold more potent than the GK peptide, used
at a similar concentration, and reduced the viral RNA by more
than 1.5 log compared to the positive control. Similar results were
obtained with all four DENV serotypes (Figure 5). From the two
concentrations used, a more efficient inhibition was observed at a
concentration of 10 mg/ml of either peptide. Neither peptide, at
any of the concentrations used, generated cytotoxic effects as
demonstrated by the IC50 values that were .290 mg/ml and
250 mg/ml for the GK and MK peptides, respectively.
The plaque reduction infectivity assay was also performed in
virus-containing supernatants to determine virus count reduction
as a result of treatment of infected C6/36 cells with the three
peptides (Table 2). The amount of virus plaques was markedly
decreased by about a hundred fold in the presence of the MK
Table 1. List of differentially expressed genes that are discussed in the text.
Tag sequence lg Nlg P-value Ensembl gene ID Description Chromosome
CATGAAGTGTTCTGAAAATAA 339 58 8.0E-57 AAEL000598 antibacterial peptide,
putative
supercont1.12
CATGTCGAATAGCGAGCTCAA 9 1 5.7E-03 AAEL014640 peptidoglycan recognition
protein-lc isoform
supercont1.1200
CATGAATGTTGCAGTCGGTGG 12 4 1.6E-02 AAEL007064 gram-negative bacteria
binding protein
supercont1.233
CATGACGCAGATCGCGTTCAC 11 5 4.3E-02 AAEL007619 toll supercont1.267
CATGGAGGAGAGAAAATTGAA 9 4 6.1E-02 AAEL007768 myd88 supercont1.279
CATGCAATATGAAAGATCTTT 790 323 6.6E-30 AAEL009670 lysozyme P, putative supercont1.417
CATGAAAGGCAAGGGCAGTTG 24 10 2.9E-03 AAEL015639 transferrin supercont1.4036
CATGAGTATTATTAGGATTGT 9 393 1.5E-92 AAEL003849 conserved hypothetical
protein, defensin
supercont1.98
CATGCAGCCCCTCACTGTCAT 30 78 2.5E-05 AAEL003857 conserved hypothetical
protein, defensin
supercont1.98
The table contains annotated DGE tags with specific occurrences generated for infected salivary glands (Ig) and uninfected salivary glands (NIg) libraries, p-value,t h e
GenBank accession number and description, and the chromosome localization are listed to identify tags. Full lists are in the Web page (http://www.skuldtech.com/
dengue_misse/).
doi:10.1371/journal.ppat.1001252.t001
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PLoS Pathogens | www.plospathogens.org 6 January 2011 | Volume 7 | Issue 1 | e1001252Figure 2. AAEL000598 mRNA expression and detection of the 3.680-kDa peptide in infected salivary glands. (A) Salivary glands were
dissected from Ae. aegypti at 3, 5, 9 and 14 days after a blood meal containing or devoid of DENV, pooled for each time point (n=10) and changes in
the expression of AAEL000598 transcripts were measured using real-time PCR. Results are expressed as fold induction of AAEL000598 transcripts in
DENV-infected salivary glands relative to those in uninfected salivary glands. (B) Salivary gland extracts from uninfected (NV) and DENV-infected (DV)
mosquitoes were analyzed for the presence of the 3.680-kDa peptide by SELDI-TOF-MS. For depletion experiments, DENV-infected salivary gland
extracts were incubated with a polyclonal Ab specific for the 3.680-kDa peptide coupled to magnetic beads and after removal of the beads
reanalyzed by SELDI-TOF-MS. Data are representative of three independent experiments (error bars represent standard error of the mean).
doi:10.1371/journal.ppat.1001252.g002
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PLoS Pathogens | www.plospathogens.org 7 January 2011 | Volume 7 | Issue 1 | e1001252Figure 3. Immunofluorescence staining of DENV-2 envelope in infected Ae. aegypti salivary glands. (A–D) Uninfected salivary gland and
DENV- infected salivary gland at (E–H) 3 dpi, (I–L) 5 dpi, (M–P) 9 dpi and (Q–T) 14 dpi. Nuclei are colored blue, DENV green and actin red. Data are
representative of two independent experiments.
doi:10.1371/journal.ppat.1001252.g003
Figure 4. Antibacterial activity of GK and MK. E.coli were cultured in the presence of various concentrations of GK (diamond), MK (squares), MT
(triangles) or SC (circles) peptides and bacterial growth was evaluated after 24 h of culture. Bacterial culture in LB medium only represents 100%
growth. MT and SC peptides are used as negative controls. Data are representative of three independent experiments (mean 6 SD).
doi:10.1371/journal.ppat.1001252.g004
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cells, either untreated or treated with MT peptide. Furthermore,
mean infectious titer correlated with RNA copy number, as
determined by quantitative RT-PCR (Figure 5).
To further investigate the antimicrobial properties of the
cecropin-like peptides, we evaluated their inhibitory effects in a
CHIKV model of infection. To this end, we used a model of
HEK293T cells. This human epithelial cell line, was reported to
be susceptible to CHIKV infection [28,29] and was thus used as
an indicator cell line for viral infectivity. As shown in Figure 6,
both GK and MK peptides inhibited the infection of HEK-293T
cells by the CHIKV 147-2 strain in a dose dependent way. The
MK peptide was more potent with inhibition levels of about 50%
at 10 mg/ml and 80% at 80 mg/ml, respectively. Under these
experimental conditions, the control MT peptide induced no
reduction of cell infection at any of the concentrations used. It is
important to note that the GK IC50 was .290 mg/ml and that of
the MK peptide was 200 mg/ml, indicating that none of the
peptides had cytotoxic effects used at these concentrations.
Leishmanicidal activity
Finally, in order to determine the spectrum of anti-pathogenic
activity of the GK and MK peptides, their capacity to kill the
human protozoan parasites L. infantum and L. braziliensis promas-
tigotes, was evaluated as well (Figure 7). Of note, whereas the MK
peptide mediated potent activity against both parasites with
respective IC50 values of ,15 mM (Figure 7A) and ,10 mM
(Figure 7B), the GK and the MT control peptides were inactive.
Circular dichroism
The difference between the GK and MK peptides in their
ability to display antimicrobial activity might be due to differences
in their molecular conformation (Supporting Information, Figure
S2). Therefore, circular dichroism (CD) spectra were used to study
the content of secondary structures of both peptides. Figure 8A
represents the CD spectra of the GK and MK peptides at 25uCi n
PBS and shows that the MK peptide contains a-helical structures,
as indicated by a negative ellipticity at wavelengths of 208 and
222 nm, as well as a CD peak at 195 nm. In contrast, the CD
spectrum of the GK peptide shows a negative band around
200 nm which is typical for the back bond of a peptide in random-
coil conformation. In order to test whether the GK peptide was
able to adopt a helical structure in a hydrophobic environment, it
was diluted in PBS containing various proportions of TFE (10–
40%) (Figure 8B). With an increasing concentration of TFE, the
conformation of the GK peptide gradually changed from a
Figure 5. Inhibition of in vitro DENV replication by GK and MK
peptides. C6/36 cells were incubated 1 h at 4uC with (A) DENV-1, (B)
DENV-2, (C) DENV-3, (D) DENV-4 and then treated with 5 and 10 mg/ml
of GK and MK peptides. DENV replication was analyzed after 24 h by
real-time RT-PCR. Cells infected with DENV and maintained in the
presence of medium alone (PC) or cultured with the MT peptide at a
concentration of 10 mg/ml (MT) are used as controls. Data are
representative of two independent experiments (mean 6 SD).
doi:10.1371/journal.ppat.1001252.g005
Table 2. Effects of GK and MK peptides on DENV growth.
Plaque Forming Units/ml





















C6/36 cells were infected with DENV (serotypes 1–4) at a MOI of 1 and were
cultured in the absence (PC) or the presence of 10 mg/ml of each of the GK, MK
or the control MT peptides. After 24 h of culture, supernatants were collected
and the presence of DENV was determined by plaque assay. Plaque Forming
Units/ml in cell culture supernatant are presented as the mean of four replicates
from two independent experiments.
doi:10.1371/journal.ppat.1001252.t002
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PLoS Pathogens | www.plospathogens.org 9 January 2011 | Volume 7 | Issue 1 | e1001252Figure 6. GK and MK CHIKV antiviral activity. 293T cells were infected with the CHIKV 37997 strain used at a MOI of 1 for 1 h at 37uC in the
presence of various concentrations of GK, MK or MT peptides. After 12 h in culture, the percentage of CHIKV-infected cells was monitored by the
detection of intracellular CHIKV antigens using a polyclonal anti-CHIK serum and FITC-conjugated secondary antibodies. Expression levels were
quantified by flow cytometry. MT peptide is shown as control. Each value is the mean of 2 separate experiments performed in duplicate (mean 6 SD).
One-way ANNOVA was employed to analyze the differences between sets of data. A value of p,0.05 was considered significant. * indicate p
values,0.05 and ** p values,0.01.
doi:10.1371/journal.ppat.1001252.g006
Figure 7. Leishmanicidal activity of GK and MK. The effect of MK (circles), MT (squares), and GK (triangles) peptides on the luciferase gene-
containing promastigotes (A) L. infantum and (B) L. braziliensis was determined after 72 h of exposure of the parasites to various concentrations of the
peptides. Untreated cultures correspond to parasite growing in culture medium only. The RLU percentage was calculated for each test sample
according to the following formula [RLU in treated wells/RLU in untreated cultures]6100. Results represent mean values 6 SD of three independent
experiments.
doi:10.1371/journal.ppat.1001252.g007
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hydrophobic environment (40% TFE/PBS). This property is
shared by many membrane-binding peptides [30]. In contrast, the
MK peptide maintained its helical conformation independently of
the concentration of TFE (data not shown).
Other immune-related genes regulated during DENV
infection of salivary glands
Another strongly up-regulated gene, with a 9-fold over-
expression in DENV-infected salivary glands, was identified as
the membrane-spanning peptidoglycan recognition protein
(PGRP-LC, AAEL014640) (Table 1). The PGRP-LC protein is
known to be important in innate immune responses in Drosophila
[31].
A member of the Gram-negative bacteria-binding protein
(GNBP) family (AAEL007064), the Toll-like receptor Toll5A
(AAEL007619) and the MYD88 factor (AAEL007768), were also
up-regulated in infected salivary glands (Table 1), suggesting that
the Toll pathway is activated in Ae. aegypti salivary gland anti-
dengue defense mechanisms.
Interestingly, the most significantly down-regulated gene
detected encodes a conserved hypothetical protein (AAEL003849)
that is also an AMP belonging to the defensin family (Table 1).
Moreover, the expression of another defensin gene (AAEL003857)
was also found to be down-regulated in infected salivary glands.
These results underscore the ability of the virus to survive the rigor
of the mosquito’s immune system.
Lysozyme P (AAEL009670) is another immune-related mos-
quito gene [32] with enhanced expression in DENV-infected
salivary glands (Table 1). Lysozyme C which has been linked to
melanization reactions has been shown to be up-regulated in the
midgut following DENV infection of Ae. aegypti [8], thereby
pointing to the importance of lysozyme family in the host defense
mechanisms of this vector. In our study, transferrin (AAEL015639)
was induced by DENV infection of the salivary gland (Table 1). It
Figure 8. Folding of GK and MK peptides in circular dichroism experiments. (A) CD spectra of the GK peptide (triangles) and the MK
peptide (squares) in PBS. (B) CD spectra of the GK peptide in 10% TFE (circles), 20% TFE (squares) and 40% TFE (triangles). Data are representative of
two independent experiments.
doi:10.1371/journal.ppat.1001252.g008
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increased when Aedes mosquito cells are exposed to bacteria,
suggesting that mosquito transferrin may act as an acute-phase
protein [33].
Discussion
DENV is not simply passively transported to humans by its
vector Ae. aegypti; rather, it intimately interacts with the mosquito,
allowing viral multiplication that induces significant biochemical
and molecular changes in the host. Following the ingestion of an
infectious blood meal, replication of DENV occurs in different
mosquito tissues, including the salivary glands. Viral replication in
this compartment is a prerequisite for subsequent injection of
infectious saliva into the human host and continuation of the
DENV transmission cycle. Accordingly, it is of crucial importance
to elucidate the immune response mounted against DENV in this
particular compartment for future elaboration of antiviral
strategies.
The comprehensive transcriptome analysis of the Ae. aegypti
salivary gland in response to DENV infection performed in this
study has allowed us to identify unique sequences of genes the
products of which are modulated following viral infection. It is of
note that, despite the availability of the completely sequenced
genome of Ae. Aegypti [10], a significant number of tags unmatched
with annotated databases was observed. Unmatched tags might
correspond to novel transcripts not yet identified in the Aedes
genome, including alternatively spliced transcripts from known
genes, as well as transcripts from novel genes. The latter possibility
is underscored by the recent demonstration that the use of novel
DGE tags as probes has permitted the identification of transcripts
and genes in the human genome that were difficult to identify by
conventional methods [34].
Among the modulated tags, the AAEL000598 sequence was the
most strongly up-regulated gene in DENV-infected salivary
glands. This sequence encodes a small cationic AMP belonging
to the cecropin family [5]. The DENV-induced up-regulation of
the AAEL000598 gene resulted in the production of a cecropin-
like peptide at 5 dpi, the identity of which was confirmed using an
antibody specific for the AEEL000598 gene product. Both the
RNA and protein expression patterns concur with the detection of
viral antigen early after the blood meal (5 dpi). This result
corroborates a recent study suggesting that the extrinsic incubation
period (EIP) for DENV may be shorter than previously reported
and that it depends on the nature of the viral strain, as well as the
genetic background of the vector [4]. As an example, short EIPs
have been observed for other vector-arbovirus interactions: EIPs
are only 2 days for CHIKV in Ae. Aegypti [35], for Rift Valley fever
virus in Culex pipiens [36] and for Venuezuelan Equine Encephalitis
virus in Ae. aegypti [37]. With respect to our data, the presence of
DENV RNA, associated with an absence of envelope expression in
salivary glands at 24 hpi, suggests either that the viral particles
present in this tissue at this time point are incomplete, or that there
is not yet enough virus present to allow detection of the viral
envelope by confocal microscopy. Investigating the assembly of
entire particles, for example by electron microscopy imaging,
would help to discriminate between these hypotheses.
Fat body tissue has been reported to express cecropin as well
and it is therefore important to rule out potential contamination of
the salivary glands, used for the DGE analysis, by the surrounding
fat body. The induction of cecropin in fat body tissue by DENV is
however rapid and transient, as, following its expression 24 hpi, it
is no longer detected at 3 dpi [38]. Therefore, the absence of
cecropin expression in fat body tissue at 5 dpi, as demonstrated in
the present study, argues for a lack of contamination during the
dissection procedure. To further rule out contamination of the
salivary gland samples by fat body tissue, we also focused on
diptericin expression in both tissues. Tag-DGE analysis of the
salivary glands RNA libraries revealed a maximum of 3 diptericin
tag-DGE counts for 6 million tag-DGEs sequenced per library.
This result is very close to background. Given that diptericin is
highly expressed in fat body tissue [38], these results confirm the
absence of contamination of samples used in the present study.
The functional properties of the AEEL00598-encoded cecropin-
like peptide were determined using two synthesized peptides MK
and GK, corresponding to the pre-protein and mature product,
respectively. Both peptides were found to display broad anti-
infectious properties and were active against DENV, CHIKV, as
well as against E. coli bacterial strain. However, in some
experiments the immature peptide was significantly more potent
than the mature peptide used at a similar concentration: although
CHIKV infection was less sensitive to the antiviral properties of
the immature peptide, both peptides interfere with Flaviviruses
and Alphaviruses, viral pathogens that belong to two different
families of RNA viruses. Moreover, the immature peptide was
efficacious against Leishmania while the mature was not, thus
confirming that the immature form of the cecropin peptide has an
even broader spectrum of activity, being able to inhibit pathogens
vectored by Aedes mosquitoes, as well as a parasite like Leishmania
that is not transmitted by mosquitoes. Based on the results from
CD spectra analysis, these differential effects may be due to
conformational differences, which are associated with the presence
of the signal sequence in the immature form of the peptide.
However, from a mechanistic point of view, the mode of action of
AMPs, their selectivity for certain pathogens, as well as their lack
of activity against normal eukaryotic cells, remain yet to be
determined. This selectivity appears to depend on the lipid
composition of the target membrane which determines its fluidity
and charge the microbial membrane showing a highly negative
electrical potential) and whether or not cholesterol is present.
Indeed, the plasma membrane of the Leishmania promastigote
shows significant differences from those of other eukaryotic cells
[39,40] because it has a high negative charge due to high levels of
lipophosphoglycan and contains a higher proportion of anionic
phospholipids. In this context, as evidenced for bacteria, AMPs are
able to alter the structure of biological membranes as a result of
the binding of positively charged regions of their a-helical peptides
to negatively charged lipids in the membrane [41]. It has been
suggested that AMPs above and beyond their ability to
permeabilize and disrupt membranes may affect microbial
viability by interacting with intracellular targets or disrupting key
intracellular processes via the alteration of cytoplasmic membrane
septum formation, the inhibition of cell-wall, nucleic-acid and
protein synthesis, as well as the inhibition of enzymatic activity,
following their translocation across the plasma membrane (review
in [42]. Such properties could explain virucidal activity of a-helical
peptides. In addition, it is possible that such peptides could inhibit
viral replication by interfering with membranes of the endoplasmic
reticulum system, as DV replication is known to depend on the
integrity of these membranes [43]. Results from structural
characterization by Nuclear Magnetic Resonance analysis and
the determination of the crystal structure of the peptides will
provide more insight into their mode of action.
Cecropin family peptides do have anti-pathogenic activities. A
recent study showed that co-overexpression of two AMPs,
cecropin A and defensin A, in transgenic Ae. aegypti mosquitoes
results in a cooperative antibacterial and anti-plasmodium action
[44]. Moreover, peptides of the cecropin family reportedly possess
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resembles a hybrid between a defensin and cecropin was shown to
have antibacterial and antiplasmodial activity, as well as antiviral
activity against DENV [46]. Such properties encourage the design
of analogs consisting of sequences containing single amino acid
replacements or hybrid peptide sequences derived from cecropins
or cecropins with other AMPs, such as thanatin, melittin,
magainin and temporin. In light of the antipathogenic properties
observed for the MK and GK peptides, it is to be expected that in
the near future a rational design approach based on these peptides
may yield derived products that are more effective at lower
concentrations. For example, the C-terminal amidation of these
peptides might enhance their stability and cationicity, as has been
demonstrated for the C-terminally amidated cecropin A of the
giant silk moth Hyalophora cecropia which is more active than
cecropin A itself [47]. Otherwise, as the antimicrobial activity of
several of these analogs is more potent than that of their parent
molecules [48], hybrid molecules based on the structure of MK
and GK peptides could be powerful effectors. Insect AMPs have
been selected throughout evolution for their low toxicity to
eukaryotic cells. Over the past decade, strains of many common
microbes have continued to develop resistance to drugs [49] and,
because of the urgent need for novel treatment modalities, insect
AMPs could serve as a template for the design of novel therapeutic
compounds.
Besides the AAEL000598 gene, several other genes were
identified the expression of which was up-regulated following
DENV infection of Ae. Aegypti salivary glands. Among these, the
PGRP-LC protein is known to be important in innate immune
responses in Drosophila [31], being involved in the signal
transduction events that lead to the induction of AMP gene
expression. PGRP-LC recognizes molecular patterns in exogenous
microbes and activates the IMD pathway in response to pathogen
infection [50,51]. This pattern recognition receptor could
therefore be involved in the up-regulation of expression of the
AAEL000598 gene.
Up-regulation of GNBP (AAEL007064), Toll5A (AAEL007619)
and MYD88 (AAEL007768) gene expression in infected salivary
glands supports the notion that the Toll pathway is activated
following DENV infection of Ae. Aegypti. This result furthermore
corroborates a recent study showing that silencing of MYD88, a
key component of the Toll pathway, results in a small but
significant increase in DENV load in the midgut of infected
mosquitoes [8]. Accordingly, following infection the Toll pathway
regulates expression of antiviral molecules. Interestingly, a
mosquito RNAi-mediated silencing of Cactus, a negative regulator
of the Toll immune pathway, has been shown to induce the
expression of innate immune response-related genes including
AAEL000598 [8]. Genetic analysis of the systemic immune
response of Drosophila has indicated that activation of the Toll
pathway accounts primarily for the response of this invertebrate to
infections by fungi and Gram-positive bacteria [52], whereas the
IMD pathway is mainly induced in response to Gram-negative
bacterial infection. For example, in Drosophila, cecropin A is
regulated preferentially, but not exclusively, by the IMD pathway
[53]. Although both pathways can be activated independently,
they usually function synergistically, as has demonstrated in flies
infected with the Drosophila C virus [54,55]. The interaction
between both pathways during the infection of mosquitoes by
DENV remains however to be established.
Like the midgut, the Ae. aegypti mosquito salivary gland
compartment harbours a potent cellular response against DENV.
The results from the analysis of the Ae. Aegypti salivary gland
transcriptome reported in the present study show that many of the
genes that are up-regulated following infection with DENV,
encode proteins that are involved in the innate immune response
and that participate in the IMD signalling pathway. Recent studies
have provided important insights into Ae. aegypti immune responses
to DENV-2 infection in the midgut [8,9,38] showing that the Toll
and the JAK-STAT pathways, as well as the RNAi machinery are
important for the mosquito’s defense against DENV infection. No
involvement of the IMD pathway in the control of DENV-2 was
reported in these studies, but this is to be expected since the
analyses were carried out 10 dpi, whereas elicitation of the IMD
pathway represents an acute response [56]. Together with these
data, the results presented here demonstrate that both the IMD
and Toll-like signaling pathways are modulated following infection
of the salivary gland by DENV-2. This is quite consistent with the
very recent data in the literature, reporting up-regulation of
cecropin in the midgut and fat body 24 h after oral infection of the
mosquito with DENV-2 [38]. Studies on the survival of DENV-
infected mosquitoes in which one of these signaling pathways is
defective could shed light on the molecular mechanisms that
underlie the interplay of these pathways, as well as on the
regulation of their respective activity.
The effectiveness of defense of the vector is likely to rely on the
arsenal of strategies present in the midgut, fat body and salivary
glands, which help the insect survive in a hostile environment that
is harboring a wide variety of potential pathogens. It is
nevertheless important to stress that, in spite of these immune
response mechanisms, DENV accumulates viral genome RNA
and infectious virus in the midgut and salivary gland, which is
subsequently transmitted to humans. This underscores the
complexity of the interaction between the virus and its vector, as
well as the notion that the escape mechanism of the virus within
the vector remains poorly explored. From an evolutionary point of
view, the mosquito immune response has evolved to fight the
infection until its detrimental fitness consequences are eliminated,
albeit not to fully eradicate the virus. In this context, it is not
paradoxical that mosquitoes can both mount an apparently robust
response to virus infection and remain competent vectors. Further
studies would be necessary to test this hypothesis. It would also be
interesting to carry out RNAi-mediated knockdown studies of this
peptide to understand his contribution in the antiviral signalling
pathways.
Finally, the results from this transcriptome analysis will facilitate
the understanding of the molecular mechanisms of the insect-virus
relationship and could help to develop novel strategies to reduce
the transmission of viral diseases, including the use of transgenic
insects or the identification of novel sources of pharmacological
compounds.
Supporting Information
Figure S1 Expression of cecropin in Aedes aegypti salivary gland
and fat body. Infected salivary gland (A), non-infected salivary
gland (B), infected fat body (C) and non-infected fat body (D) were
dissected at day 5 post infection. Cecropin was visualized in green
by immunohistochemistry assay. Nucleuses were stained in bleu by
Hoechst.
Found at: doi:10.1371/journal.ppat.1001252.s001 (0.41 MB EPS)
Figure S2 Secondary structure prediction of MK and GK
peptides. The predicted secondary structures for (A) MK and (B)
GK were generated using the Advanced Protein Secondary
Structure Prediction Server [57]. The lines in the order are the
original amino acid sequence, string of the predicted structure and
confidence level of the secondary structure prediction. The amino
acid sequence corresponding to the signal peptide, the putative
Dengue Virus-Induced Broad-Spectrum AMP
PLoS Pathogens | www.plospathogens.org 13 January 2011 | Volume 7 | Issue 1 | e1001252cleavage sites for signal peptidase (black arrow) and a-helix (H), b-
sheet (E) coiled coil (C) structures are represented.
Found at: doi:10.1371/journal.ppat.1001252.s002 (0.49 MB EPS)
Table S1 List of differentially expressed genes. The Web page
(http://www.skuldtech.com/dengue_misse/) contains filtered
DGE data and is classified in 3 pages: annotated tags up- and
down-regulated, and unknown tags. Each table includes the tag
sequence (CATG+10nt), specific occurrences of each DGE tag,
generated for infected salivary glands (Ig) and uninfected salivary
glands (NIg) libraries, and p-value. The direct web link to Ensembl
database, the GenBank accession number and description, and the
chromosome localization are listed to identify tags.
Found at: doi:10.1371/journal.ppat.1001252.s003 (0.02 MB
DOC)
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